Literature DB >> 29517816

Stroke survivors' and carers' experiences of a systematic voiding programme to treat urinary incontinence after stroke.

Josephine Me Gibson1,2, Lois H Thomas3, Joanna J Harrison1, Caroline L Watkins1,2.   

Abstract

AIMS AND
OBJECTIVES: To explore the views and experiences of stroke survivors and carers about a systematic voiding programme for poststroke incontinence.
BACKGROUND: Urinary incontinence after stroke is common and associated with poorer functional outcome. Structured assessment and management are potentially effective interventions, but it is important that there is a good understanding of stroke survivors' and carers' views of their acceptability and implementation.
DESIGN: A qualitative study within a feasibility trial.
METHODS: Sixteen participants (12 stroke survivors and four carers) were interviewed using a structured schedule shortly before discharge from one of six inpatient stroke units across six hospitals. Interviews were audio-recorded and transcribed verbatim, and thematic analysis was conducted.
FINDINGS: Participants included seven male and five female stroke survivors (mean age 76 years) and four female carers (two wives and two daughters). Themes relating to the preliminary (assessment) phase of the programme were as follows: physical impact, psychological impact, beliefs about incontinence, and the assessment process itself. Main themes relating to the implementation of the programme included the following: timed voiding decisions, adapting the programme or the timed voiding schedule, and urinary incontinence management techniques. Participants felt that the programme helped them to re-establish a regular pattern of micturition and to regain autonomy.
CONCLUSIONS: The effectiveness of a systematic voiding programme may partly lie in its educational component, challenging patients' and carers' assumptions that poststroke incontinence is inevitable. Individual adaptation of the programme and the ability to incorporate it alongside other aspects of care are likely to be key factors influencing implementation. RELEVANCE TO CLINICAL PRACTICE: Urinary incontinence is common after stroke. To maximise benefits from a systematic voiding programme, nurses should support stroke survivors to overturn erroneous beliefs, to participate in tailoring of the programme, and in self-management where appropriate.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  adult nursing; incontinence; patients’ experience; qualitative study; stroke

Mesh:

Year:  2018        PMID: 29517816     DOI: 10.1111/jocn.14346

Source DB:  PubMed          Journal:  J Clin Nurs        ISSN: 0962-1067            Impact factor:   3.036


  5 in total

1.  I leaked, then I Reddit: experiences and insight shared on urinary incontinence by Reddit users.

Authors:  Chris Du; Wai Lee; Dena Moskowitz; Alvaro Lucioni; Kathleen C Kobashi; Una J Lee
Journal:  Int Urogynecol J       Date:  2019-12-12       Impact factor: 2.894

2.  Factors affecting the delivery of complex rehabilitation interventions in research with neurologically impaired adults: a systematic review.

Authors:  Jain Anne Holmes; Philippa Logan; Richard Morris; Kathryn Radford
Journal:  Syst Rev       Date:  2020-11-25

3.  Promoting urinary continence in people suffering a stroke: Effectiveness of a complex intervention-An intervention study.

Authors:  Myrta Kohler; Stefan Ott; Jeanette Mullis; Hanna Mayer; Jürg Kesselring; Susi Saxer
Journal:  Nurs Open       Date:  2022-01-11

4.  Effectiveness of repetitive transcranial magnetic stimulation against poststroke urinary incontinence: a study protocol for a randomized controlled trial.

Authors:  Wei Jiang; Wen Tang; Yunling Song; Yali Feng; Yuesan Zhou; Lang Li; Botao Tan
Journal:  Trials       Date:  2022-08-13       Impact factor: 2.728

5.  Effectiveness of neuromuscular electrical stimulation therapy in patients with urinary incontinence after stroke: A randomized sham controlled trial.

Authors:  Gai-Yan Guo; Yong-Gang Kang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.